(NASDAQ: TECH) Bio Techne's forecast annual revenue growth rate of 6.11% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 152.36%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.68%.
Bio Techne's revenue in 2025 is $1,196,016,000.On average, 5 Wall Street analysts forecast TECH's revenue for 2025 to be $193,391,982,455, with the lowest TECH revenue forecast at $191,100,343,402, and the highest TECH revenue forecast at $195,111,818,359. On average, 5 Wall Street analysts forecast TECH's revenue for 2026 to be $210,764,554,115, with the lowest TECH revenue forecast at $207,885,303,145, and the highest TECH revenue forecast at $216,711,338,487.
In 2027, TECH is forecast to generate $236,023,962,193 in revenue, with the lowest revenue forecast at $227,815,101,165 and the highest revenue forecast at $244,232,823,220.